# Trade Mark Journal No.2025/041 10 October 2025

## WO0000001864030 (5,42)

Office of origin: United States of America

Date of International Registration:22 May 2025
Date of designation in the UK: 22 May 2025

International priority date claimed: 4 December 2024 (United States of America) (98885158)

Class 5
  Pharmaceutical preparations for the treatment of renal, liver and/or cardiometabolic conditions and/or diseases.
Class 42
  Pharmaceutical product evaluation; pharmaceutical research and development; scientific and technological services, namely, research and design in the field of small molecules, peptides and biologics.

Metsera, Inc.

Representative: David Cole Cadwalader, Wickersham & Taft LLP, 200 Liberty Street, New York NY 10281, UNITED STATES OF AMERICA